AAAAAA

   
Results: 1-10 |
Results: 10
Antiplatelet therapy and other interventions after revascularisation procedures in patients with peripheral arterial disease: a meta-analysis
Authors: Girolami, B Bernardi, E Prins, MH ten Cate, JW Prandoni, P Simioni, P Andreozzi, GM Girolami, A Buller, HR
Citation: B. Girolami et al., Antiplatelet therapy and other interventions after revascularisation procedures in patients with peripheral arterial disease: a meta-analysis, EUR J VAS E, 19(4), 2000, pp. 370-380
Clinical outcome of patients with internal carotid artery occlusion: A prospective follow-up study
Authors: Verlato, F Camporese, G Bernardi, E Salmistraro, G Rocco, S Mayellaro, V Busonera, F Andreozzi, GM
Citation: F. Verlato et al., Clinical outcome of patients with internal carotid artery occlusion: A prospective follow-up study, J VASC SURG, 32(2), 2000, pp. 293-298
Nomograms for the administration of unfractionated heparin in the initial treatment of acute thromboembolism - an overview
Authors: Bernardi, E Piccioli, A Oliboni, G Zuin, R Girolami, A Prandoni, P
Citation: E. Bernardi et al., Nomograms for the administration of unfractionated heparin in the initial treatment of acute thromboembolism - an overview, THROMB HAEM, 84(1), 2000, pp. 22-26
NMR studies of the R2 repeat and related peptide fragments of the DNA binding domain of c-Myb. New light on the structure and folding of R2
Authors: Segalas, I Desjardins, S Oulyadi, H Prigent, Y Tribouillard, S Bernardi, E Schoofs, AR Davoust, D Toma, F
Citation: I. Segalas et al., NMR studies of the R2 repeat and related peptide fragments of the DNA binding domain of c-Myb. New light on the structure and folding of R2, J CHIM PHYS, 96(9-10), 1999, pp. 1580-1584
Antithrombotic drugs in the primary medical management of intermittent claudication: A meta-analysis
Authors: Girolami, B Bernardi, E Prins, MH ten Cate, JW Prandoni, P Hettiarachchi, R Marras, E Stefani, PM Girolami, A Buller, HR
Citation: B. Girolami et al., Antithrombotic drugs in the primary medical management of intermittent claudication: A meta-analysis, THROMB HAEM, 81(5), 1999, pp. 715-722
Structural requirements of 5-hydroxytryptamine-moduline analogues to interact with the 5-hydroxytryptamine(1B) receptor
Authors: Plantefol, M Rousselle, JC Massot, O Bernardi, E Schoofs, AR Pourrias, B Ollivier, R Fillion, G
Citation: M. Plantefol et al., Structural requirements of 5-hydroxytryptamine-moduline analogues to interact with the 5-hydroxytryptamine(1B) receptor, J NEUROCHEM, 73(6), 1999, pp. 2617-2620
Endoproteolytic activity in mammalian brain membranes cleaves 5-hydroxytryptamine-moduline into dipeptides
Authors: Plantefol, M Rousselle, JC Bernardi, E Schoofs, AR Pourrias, B Fillion, G
Citation: M. Plantefol et al., Endoproteolytic activity in mammalian brain membranes cleaves 5-hydroxytryptamine-moduline into dipeptides, EUR J PHARM, 376(1-2), 1999, pp. 109-117
Treatment of intermittent claudication with physical training, smoking cessation, pentoxifylline, or nafronyl - A meta-analysis
Authors: Girolami, B Bernardi, E Prins, MH ten Cate, JW Hettiarachchi, R Prandoni, P Girolami, A Buller, HR
Citation: B. Girolami et al., Treatment of intermittent claudication with physical training, smoking cessation, pentoxifylline, or nafronyl - A meta-analysis, ARCH IN MED, 159(4), 1999, pp. 337-345
Intermittent claudication revisited: The value of medical therapy - Reply
Authors: Girolami, B Bernardi, E Prins, M
Citation: B. Girolami et al., Intermittent claudication revisited: The value of medical therapy - Reply, ARCH IN MED, 159(16), 1999, pp. 1956-1957
The cauchy problem for hyperbolic systems with multiple characteristics
Authors: Benvenuti, S Bernardi, E Bove, A
Citation: S. Benvenuti et al., The cauchy problem for hyperbolic systems with multiple characteristics, B SCI MATH, 122(8), 1998, pp. 603-634
Risultati: 1-10 |